Maha FDA seizes medicines worth Rs 9.09 lakh from Mumbai children’s hospital over alleged illegal sale

Mumbai: In a major crackdown aimed at safeguarding public health, the Maharashtra Food and Drug Administration (FDA) has seized an allopathic medicine stock worth over Rs 9.09 lakh from a paediatric hospital in Govandi, Mumbai. The hospital was found illegally retailing medicines without a valid drug license through an unqualified receptionist.

Acting on a special enforcement drive, FDA officials inspected the hospital located at Shivajinagar, Govandi East, on Thursday. During the inspection, officials allegedly discovered that the hospital’s director had stocked massive quantities of allopathic medicines across two separate rooms.

According to FDA, these prescription drugs were being sold directly to patients via a receptionist who had only cleared Class 12. Officials said the individual lacked any statutory or technical qualifications required for dispensing pharmaceuticals under the Pharmacy Act.

FDA officials also seized the hospital’s sales bill book

Furthermore, the FDA seized the hospital’s sales bill book and alleged that several statutory details were missing from the bills issued to patients. According to the agency, the bills contained only the patient’s name, date, medicine name and amount charged.

The FDA alleged that the records did not include details such as batch numbers, manufacturing dates, expiry dates, and manufacturers’ names, which are required under applicable regulations.

Officials seized the medicine stock, valued at Rs 9,09,215.28. Officials said legal proceedings are being initiated under the Drugs and Cosmetics Act, 1940.

Speaking on the action, FDA Commissioner Tukaram Mundhe said, “The Food and Drug Administration will not tolerate any compromise regarding patient health. Strict action will be taken against those selling medicines without a valid license, distributing drugs through unqualified personnel, or violating statutory provisions. Citizens must purchase medicines only from licensed pharmacies and ensure they obtain a proper bill containing all statutory details during every purchase.”

Related Posts

CREATE Medicines expands targeted in vivo CAR platform through strategic research collaboration and exclusive license pact with Monash University

CREATE Medicines, Inc. (CREATE), a clinical-stage biotechnology company pioneering in vivo immune programming, announced a strategic research collaboration with Australia’s Monash University and its world-leading Monash Institute of Pharmaceutical Sciences…

CBN Dismantles Major Inter-State Counterfeit Drug Network In Bihar Under ‘Operation Vajra’; Mastermind Arrested

PATNA / NEW DELHI: In a major crackdown on organized pharmaceutical crime and illicit drug trafficking, the Central Bureau of Narcotics (CBN), Madhya Pradesh Unit (Neemuch), has dismantled a massive…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

CREATE Medicines expands targeted in vivo CAR platform through strategic research collaboration and exclusive license pact with Monash University

CREATE Medicines expands targeted in vivo CAR platform through strategic research collaboration and exclusive license pact with Monash University

CBN Dismantles Major Inter-State Counterfeit Drug Network In Bihar Under ‘Operation Vajra’; Mastermind Arrested

CBN Dismantles Major Inter-State Counterfeit Drug Network In Bihar Under ‘Operation Vajra’; Mastermind Arrested

Ministry of Ayush signs MoU with IndiaAI to harness AI for the future of traditional medicine

Ministry of Ayush signs MoU with IndiaAI to harness AI for the future of traditional medicine

BFUHS Pharmacy Exam Cheating Racket Busted; Punjab Police Arrest 35, Say No Paper Leak

BFUHS Pharmacy Exam Cheating Racket Busted; Punjab Police Arrest 35, Say No Paper Leak

Rajasthan Raises Govt Blood Centres’ Share in Voluntary Donation Camps to 50%

Rajasthan Raises Govt Blood Centres’ Share in Voluntary Donation Camps to 50%

FSSAI suspends licence of Dior Pharmaceuticals for violations at nutraceutical plant

FSSAI suspends licence of Dior Pharmaceuticals for violations at nutraceutical plant